260 related articles for article (PubMed ID: 17382727)
1. Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma.
Bermejo C; Busby JE; Spiess PE; Heller L; Pagliaro LC; Pettaway CA
J Urol; 2007 Apr; 177(4):1335-8. PubMed ID: 17382727
[TBL] [Abstract][Full Text] [Related]
2. Melanoma of the penis, scrotum and male urethra: a 40-year single institution experience.
Sánchez-Ortiz R; Huang SF; Tamboli P; Prieto VG; Hester G; Pettaway CA
J Urol; 2005 Jun; 173(6):1958-65. PubMed ID: 15879790
[TBL] [Abstract][Full Text] [Related]
3. Contemporary morbidity from lymphadenectomy for penile squamous cell carcinoma: the M.D. Anderson Cancer Center Experience.
Bevan-Thomas R; Slaton JW; Pettaway CA
J Urol; 2002 Apr; 167(4):1638-42. PubMed ID: 11912379
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy in advanced penile carcinoma.
Leijte JA; Kerst JM; Bais E; Antonini N; Horenblas S
Eur Urol; 2007 Aug; 52(2):488-94. PubMed ID: 17316964
[TBL] [Abstract][Full Text] [Related]
5. [Dramatic response of penile cancer with inguinal lymph node metastases to neoadjuvant chemotherapy with paclitaxel, ifosfamide and cisplatin : a case report].
Kubota Y; Nakano M; Nagai S; Matsuoka K; Arakawa H; Horie K; Deguchi T; Kato H
Hinyokika Kiyo; 2015 Jan; 61(1):33-7. PubMed ID: 25656018
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
Finnegan V; Parsons JT; Greene BD; Sharma V
Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.
de Vries RR; Nieuwenhuijzen JA; Meinhardt W; Bais EM; Horenblas S
Eur J Surg Oncol; 2009 Apr; 35(4):352-5. PubMed ID: 18722076
[TBL] [Abstract][Full Text] [Related]
8. Taxanes in combination with cisplatin and fluorouracil for advanced penile cancer: preliminary results.
Pizzocaro G; Nicolai N; Milani A
Eur Urol; 2009 Mar; 55(3):546-51. PubMed ID: 18649992
[TBL] [Abstract][Full Text] [Related]
9. Multi-institutional long-term experience with conservative surgery for invasive penile carcinoma.
Bissada NK; Yakout HH; Fahmy WE; Gayed MS; Touijer AK; Greene GF; Hanash KA
J Urol; 2003 Feb; 169(2):500-2. PubMed ID: 12544296
[TBL] [Abstract][Full Text] [Related]
10. The role of radiation therapy after incomplete resection of penile cancer.
Langsenlehner T; Mayer R; Quehenberger F; Prettenhofer U; Langsenlehner U; Pummer K; Kapp KS
Strahlenther Onkol; 2008 Jul; 184(7):359-63. PubMed ID: 19016034
[TBL] [Abstract][Full Text] [Related]
11. Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases.
Gallagher DJ; Zheng J; Capanu M; Haviland D; Paty P; Dematteo RP; D'Angelica M; Fong Y; Jarnagin WR; Allen PJ; Kemeny N
Ann Surg Oncol; 2009 Jul; 16(7):1844-51. PubMed ID: 19224284
[TBL] [Abstract][Full Text] [Related]
12. Activity and toxicity of paclitaxel in pretreated metastatic penile cancer patients.
Di Lorenzo G; Cartenì G; Autorino R; Gonnella A; Perdonà S; Ferro M; Longo N; Rescigno P; Doria F; Faiella A; Altieri V; Palmieri G; Imbimbo C; Mirone V; De Placido S
Anticancer Drugs; 2009 Apr; 20(4):277-80. PubMed ID: 19262371
[TBL] [Abstract][Full Text] [Related]
13. Morbidity of prophylactic inguinal lymphadenectomy with saphenous vein preservation for squamous cell penile carcinoma.
Milathianakis C; Bogdanos J; Karamanolakis D
Int J Urol; 2005 Aug; 12(8):776-8. PubMed ID: 16174057
[TBL] [Abstract][Full Text] [Related]
14. [Multiple metastases of the penile cancer: an experience of combination chemotherapy].
Mizutani K; Seike K; Sugawara T; Masue T; Yokoi S; Ehara H; Takahashi Y; Ishihara S; Deguchi T
Hinyokika Kiyo; 2004 Mar; 50(3):223-6. PubMed ID: 15148780
[TBL] [Abstract][Full Text] [Related]
15. Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy.
Miyata H; Yoshioka A; Yamasaki M; Nushijima Y; Takiguchi S; Fujiwara Y; Nishida T; Mano M; Mori M; Doki Y
Cancer; 2009 Jul; 115(14):3324-34. PubMed ID: 19452547
[TBL] [Abstract][Full Text] [Related]
16. Comparison of morphologic features and outcome of resected recurrent and nonrecurrent squamous cell carcinoma of the penis: a study of 81 cases.
Chaux A; Reuter V; Lezcano C; Velazquez EF; Torres J; Cubilla AL
Am J Surg Pathol; 2009 Sep; 33(9):1299-306. PubMed ID: 19471153
[TBL] [Abstract][Full Text] [Related]
17. The value of squamous cell carcinoma antigen in the prognostic evaluation, treatment monitoring and followup of patients with penile cancer.
Zhu Y; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Shen YJ
J Urol; 2008 Nov; 180(5):2019-23. PubMed ID: 18801542
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
19. Association between lymph node density and disease specific survival in patients with penile cancer.
Svatek RS; Munsell M; Kincaid JM; Hegarty P; Slaton JW; Busby JE; Gaston KE; Spiess PE; Pagliaro LC; Tamboli P; Pettaway CA
J Urol; 2009 Dec; 182(6):2721-7. PubMed ID: 19837433
[TBL] [Abstract][Full Text] [Related]
20. Partial penectomy for patients with squamous cell carcinoma of the penis: the Memorial Sloan-Kettering experience.
Korets R; Koppie TM; Snyder ME; Russo P
Ann Surg Oncol; 2007 Dec; 14(12):3614-9. PubMed ID: 17896151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]